Canon U.S.A. has expanded its canon beyond cameras. The Americas arm of Tokyo-based printer and peripherals giant
sells and services office and consumer imaging equipment, including copiers, printers, fax machines, and scanners. Its focus on cameras hasn't softened, though, offering still and video digital cameras for both consumers and professionals in photography, broadcast, and motion pictures. Industrial and other products include semiconductor and LCD lithography equipment, small motors, and medical equipment such as eye care cameras, diagnostics, and radiography systems.
Canon U.S.A. oversees subsidiaries
, Canon Latin America, and Canon Mexicana. It also has various sales, R&D, and manufacturing subsidiaries, including toner recycling facility Industrial Resource Technologies; toner cartridge and mold maker
; and Custom Integrated Technology, which re-purposes and repairs copy machines and printers.
The company operates from offices and subsidiaries across North and South America, including Argentina, Brazil, Canada, Chile, Mexico, Panama, and the US.
The Americas account for about 28% of Canon's global sales, or about $11 billion. Revenue in 2014 fell slightly from 2013 because of a slowdown in sales of digital cameras.
Canon U.S.A. established its own research and development group in 2012 to work on medical devices. The move ramped up and in 2015 the company established Canon BioMedical, a subsidiary for its worldwide biomedical business.
Expanding beyond imaging, the new unit conduct development, manufacturing and marketing operations related to Canon's life science and molecular diagnostics platform and look for uses for Canon technology into other medical fields. Potential markets include life science, health care, and medical analysis. The company also will look for strategic partnerships to leverage its technologies.
One such deal is with Spartan Bioscience, which develops on-demand DNA testing. Canon invested in Spartan to help pay for the R&D of diagnostic testing products. Possible products include those for rapid genetic testing.
Canon U.S. Life Sciences, a subsidiary of Canon U.S.A., is collaborating with T2 Biosystems to develop a diagnostic test panel for rapidly detecting Lyme disease, a tick-born bacterial infection that can cause joint inflammation, neurological disorders, and cognitive defects. Faster detection of Lyme disease can improve outcomes.